Skip to main content
    I

    ICU Medical Inc (ICUI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $176.91
    -4.96 (-2.73%)

    Market Cap: $4.55B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    ICU Medical Inc (ICUI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    ICU Medical (ICUI) has a market cap of $4.55B and an enterprise value of $5.40B. Its return on invested capital of 3.22% compares with a 7.13% median across 9 similar companies.

    Total Valuation

    Enterprise value is 18.69% above the market cap, as debt exceeds cash.

    Market Cap$4.55B
    Enterprise Value$5.40B
    Latest price (Nov 17, 2026)$176.91

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.03% in the quarter ended Sep 30, 2026 and grew 1.16% a year over 2 years.

    Shares Outstanding25.01M
    Shares Change (YoY)+1.30%
    Shares Change (QoQ)+0.03%
    Share Count Growth (2Y CAGR)+1.16%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 2.0x. Its year-end P/E ranged from 14.8x to 33.0x from 2016 to 2025.

    P/E Ratio22.1x
    Forward P/E19.5x
    P/S Ratio2.0x
    Forward P/S2.1x
    P/B Ratio2.0x
    P/TBV Ratio25.7x
    P/FCF Ratio21.2x
    P/OCF Ratio16.3x
    PEG Ratio1.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 16.2x EBITDA and 25.3x free cash flow.

    EV / Earnings89.5x
    EV / Sales2.5x
    EV / EBITDA16.2x
    EV / EBIT50.2x
    EV / FCF25.3x

    Price Statistics

    The stock is up 29.60% over 52 weeks and trades 7.66% above its 50-day average.

    Beta (1Y)1.06
    52-Week Change+29.60%
    1-Month Change+9.72%
    3-Month Change-5.53%
    6-Month Change+43.06%
    5-Year Change-30.05%
    10-Year Change+17.57%
    Total Return (1Y)+29.60%
    Total Return (3Y CAGR)+27.38%
    Total Return (5Y CAGR)-6.42%
    Return vs SPY (1Y)+20.43%
    Max Drawdown (1Y)-27.18%
    Max Drawdown (3Y)-41.20%
    Sharpe Ratio (1Y)0.79
    Correlation with SPY (1Y)0.41
    50-Day Average$164.33
    200-Day Average$149.88
    52-Week Range$113.37 to $192.85
    RSI (14 Days)57.3
    Average Volume (20 Days)294.69K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.37x current liabilities, and total debt is 0.53x shareholder equity.

    Current Ratio2.37x
    Quick Ratio1.19x
    Debt / Equity0.53x
    Debt / EBITDA3.53x
    Debt / FCF5.52x
    Interest Coverage1.58x

    Returns and Efficiency

    Return on invested capital is 3.22% over the last 12 months, against a 5-year average of 0.49%.

    Return on Equity (ROE)2.75%
    Return on Assets (ROA)1.53%
    Return on Invested Capital (ROIC)3.22%
    Return on Capital Employed (ROCE)3.14%
    ROE (5Y Average)-0.90%
    ROA (5Y Average)0.08%
    ROIC (5Y Average)0.49%
    Asset Turnover0.54x
    Inventory Turnover2.15x
    Receivables Turnover11.20x
    Cash Conversion Cycle162 days

    Scores

    ICUI has an Altman Z-Score of 2.65, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score2.65
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $2.18B over the last 12 months is down 5.92% from the 12 months before.

    Revenue$2.18B
    Revenue Growth (YoY)-5.92%
    Gross Profit$879.02M
    Operating Income$110.66M
    Pretax Income$39.45M
    Net Income$60.33M
    EBITDA$325.95M
    EBIT$107.57M
    Reported EPS (TTM)$8.00

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 55.58% of the $3.94B in total assets.

    Cash and Equivalents$301.78M
    Total Debt$1.15B
    Net Debt$850.07M
    Net Debt Per Share$33.99
    Working Capital$705.23M
    Shareholder Equity$2.19B
    Book Value Per Share$87.63
    Tangible Book Value$172.17M
    Tangible Book Per Share$6.88
    Total Assets$3.94B
    Total Liabilities$1.75B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $70.64M of capital spending, operating cash flow left $208.60M of free cash flow.

    Operating Cash Flow$279.24M
    Capital Expenditures$70.64M
    Free Cash Flow$208.60M
    FCF Per Share$8.34
    Depreciation and Amortization$225.13M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.07%, against a 5-year average of 2.44%.

    Gross Margin40.27%
    Operating Margin5.07%
    Pretax Margin1.81%
    Net Margin2.76%
    EBITDA Margin14.93%
    EBIT Margin4.93%
    FCF Margin9.56%
    Gross Margin (5Y Average)34.43%
    Operating Margin (5Y Average)2.44%
    Net Margin (5Y Average)-0.33%

    Growth

    Revenue fell 0.72% a year over 3 years, and EPS grew 3.83% a year.

    Revenue Growth (3Y CAGR)-0.72%
    Revenue Growth (5Y CAGR)+11.91%
    EPS Growth (3Y CAGR)+3.83%
    EPS Growth (5Y CAGR)+0.53%
    FCF Growth (5Y CAGR)-6.83%
    Book Value Per Share Growth (2Y CAGR)-1.10%

    Revenue and profit by year

    Dividends and Yields

    ICUI does not pay a dividend. Its free cash flow yield is 4.72%.

    Earnings Yield4.52%
    FCF Yield4.72%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 3-for-2 forward split on Mar 18, 2002.

    Last Split DateMar 18, 2002
    Split TypeForward split
    Split Ratio3:2

    Peer Position

    Against 10 similar companies, ICUI has the 4th highest P/E.

    P/E Ratio22.1x vs 20.1x median
    P/S Ratio2.0x vs 2.9x median
    ROIC3.22% vs 7.13% median
    Revenue Growth (Trailing 4 Quarters, YoY)-5.92% vs +8.97% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 1.27% and EPS growth at 14.98% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+1.27%
    EPS Growth Forecast (2Y CAGR)+14.98%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ICUI

    What is ICUI's market cap?

    ICU Medical has a market cap of $4.55B. Its enterprise value, which adds debt and subtracts cash, is $5.40B.

    What is ICUI's P/E ratio?

    ICU Medical has a trailing P/E ratio of 22.1x and a forward P/E of 19.5x.

    How many shares of ICUI are outstanding?

    ICU Medical has 25.01M shares outstanding. The count is up 1.30% from a year earlier.

    Does ICUI pay a dividend?

    No. ICU Medical does not pay a dividend.

    How much debt does ICUI have?

    ICU Medical has $1.15B of total debt and $301.78M of cash and equivalents, a net debt position of $850.07M.